From planta to pharma with glycosylation in the toolbox
Plant-specific glycosylation has long been a major limitation to the extensive use of plant-made pharmaceuticals in human therapy. Our goal here is to highlight the progress recently made towards humanization of N -glycosylation in plants and to illustrate that plant-typical N - and O -glycosylation...
Saved in:
Published in | Trends in biotechnology (Regular ed.) Vol. 25; no. 7; pp. 317 - 323 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Oxford
Elsevier Ltd
01.07.2007
Elsevier Science Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Plant-specific glycosylation has long been a major limitation to the extensive use of plant-made pharmaceuticals in human therapy. Our goal here is to highlight the progress recently made towards humanization of N -glycosylation in plants and to illustrate that plant-typical N - and O -glycosylation progressively emerge as additional advantages for using this promising expression system. |
---|---|
Bibliography: | http://dx.doi.org/10.1016/j.tibtech.2007.04.008 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Feature-3 ObjectType-Review-1 |
ISSN: | 0167-7799 1879-3096 |
DOI: | 10.1016/j.tibtech.2007.04.008 |